Schizoaffective Disorders Completed Phase 3 Trials for D-Serine (DB03929)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00237848D-Serine for Enhancing Cognitive Retraining for the Treatment of SchizophreniaTreatment